Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-09-22 00:00:00 ET · period of report 2025-09-22 · accession 0001193125-25-211788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-09-22 | 2025-09-22 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $115.96 | -10.0K | 0 | -100% | -$1.16M |
| DT | 2025-09-22 | 2025-09-22 | AXSM | Jacobson Mark L. | COO | M - OptEx | $2.85 | +10.0K | 10.0K | New | +$28.5K |
| DT | 2025-09-22 | 2025-09-22 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -10.0K | 35.4K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-22 | S | D | 10,000 | $115.96 | 0 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $115.11 and $116.55. |
| 2 | Common | Common Stock | 2025-09-22 | M | A | 10,000 | $2.85 | 10,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-09-22 | M | D | 10,000 | $0.00 | 35,378 | D | $2.85 · 2019-03-12 to 2028-03-12 | 10,000 Common Stock |